LYPLAL1 and small cell lung carcinoma: The lysophospholipase-like 1-divergent transcript (LYPLAL1-DT) has been shown to act as a small cell lung cancer (SCLC) oncogenic lncRNA by in vitro and in vivo studies, promoting cell proliferation, migration, and invasion [62].